Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis

Abstract Objective Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of suspected adverse reactions related to medicinal products (EudraVigilance)...

Full description

Bibliographic Details
Main Authors: Trygve Holmøy, Børre Fevang, David Benee Olsen, Olav Spigset, Lars Bø
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Research Notes
Subjects:
Multiple sclerosis
Treatment
Alemtuzumab
Adverse event
Online Access:http://link.springer.com/article/10.1186/s13104-019-4507-6

Internet

http://link.springer.com/article/10.1186/s13104-019-4507-6

Similar Items